Overview

Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders

Status:
Not yet recruiting
Trial end date:
2023-01-19
Target enrollment:
Participant gender:
Summary
An open-label, drug-drug interaction study with TPOXX and phosphate binders.
Phase:
Phase 4
Details
Lead Sponsor:
SIGA Technologies
Collaborators:
Biomedical Advanced Research and Development Authority
PPD
Treatments:
Calcium acetate
Sevelamer